Amyris Inc
F:3A01
Gross Margin
Gross Margin shows how much money a company keeps from each dollar of sales after paying for the products it sells. It tells how profitable the company`s core business is before other expenses.
Gross Margin shows how much money a company keeps from each dollar of sales after paying for the products it sells. It tells how profitable the company`s core business is before other expenses.
Peer Comparison
| Country | Company | Market Cap |
Gross Margin |
||
|---|---|---|---|---|---|
| US |
A
|
Amyris Inc
F:3A01
|
14.4m EUR |
Loading...
|
|
| US |
|
Sherwin-Williams Co
NYSE:SHW
|
91.3B USD |
Loading...
|
|
| US |
|
Ecolab Inc
NYSE:ECL
|
81.8B USD |
Loading...
|
|
| JP |
|
Shin-Etsu Chemical Co Ltd
TSE:4063
|
9.8T JPY |
Loading...
|
|
| CN |
|
Wanhua Chemical Group Co Ltd
SSE:600309
|
262.9B CNY |
Loading...
|
|
| CH |
|
Givaudan SA
SIX:GIVN
|
28.4B CHF |
Loading...
|
|
| US |
|
PPG Industries Inc
NYSE:PPG
|
28.2B USD |
Loading...
|
|
| DK |
|
Novozymes A/S
CSE:NZYM B
|
165.6B DKK |
Loading...
|
|
| IN |
|
Asian Paints Ltd
NSE:ASIANPAINT
|
2.4T INR |
Loading...
|
|
| CH |
|
Sika AG
F:SIKA
|
19.9B EUR |
Loading...
|
|
| CH |
D
|
DSM-Firmenich AG
AEX:DSFIR
|
18.2B EUR |
Loading...
|
Market Distribution
| Min | -24 813% |
| 30th Percentile | 28.9% |
| Median | 43% |
| 70th Percentile | 60.5% |
| Max | 10 905 714.3% |
Other Profitability Ratios
Amyris Inc
Glance View
Amyris, Inc. engages in the provision of bioscience solutions. The company is headquartered in Emeryville, California and currently employs 980 full-time employees. The company went IPO on 2010-09-28. The firm applies its Lab-to-Market biotechnology platform to engineer, manufacture and market high performance, natural and sustainably sourced products using its computational tools, strain construction tools, screening and analytics tools, and advanced lab automation and data integration. The firm's biotechnology platform enables users to rapidly engineer microbes and use them as catalysts to metabolize renewable, plant-sourced sugars into high-value ingredients that it manufactures at industrial scale. Through the combination of its biotechnology platform and industrial fermentation process, the Company has developed, produced, and commercialized many distinct molecules. The firm is focused on three market areas, Health & Wellness, Clean Beauty and Flavor & Fragrance. Its brands include Biofene, Hemisqualane, Biossance, clean beauty skincare, Pipette, clean baby skincare and Purecane.
See Also
Gross Margin is calculated by dividing the Gross Profit by the Revenue.
The current Gross Margin for Amyris Inc is 3.4%, which is in line with its 3-year median of 3.4%.
Over the last 3 years, Amyris Inc’s Gross Margin has decreased from 58% to 3.4%. During this period, it reached a low of 3.4% on May 1, 2023 and a high of 75.4% on Jun 30, 2021.
